2nd Quarter - Report

HOLLAND & KNIGHT LLP for TEVA PHARMACEUTICALS USA, INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Drug Pricing; Intellectual property

Foreign entity interest: Teva Pharmaceuticals USA, Inc. is a subsidiary of Teva Pharmaceutical Industries, LTD, headquartered in Israel.

LobbyistCovered position, as disclosed
PAUL S. BOCK —
KERRY FEEHERY New —
MICHAEL WERNER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Drug pricing; Intellectual property.

Foreign entity interest: Teva Pharmaceuticals USA, Inc. is a subsidiary of Teva Pharmaceutical Industries, LTD, headquartered in Israel.

LobbyistCovered position, as disclosed
PAUL S. BOCK —
KERRY FEEHERY New —
MICHAEL WERNER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Drug pricing; Intellectual property.

Foreign entity interest: Teva Pharmaceuticals USA, Inc. is a subsidiary of Teva Pharmaceutical Industries, LTD, headquartered in Israel.

LobbyistCovered position, as disclosed
PAUL S. BOCK —
KERRY FEEHERY New Staff Asst., Special Asst., Dep. Press Sec., Sen. Connie Mac; Press Sec., Joint Econ. Cmte.; Policy Analyst, Sen. Budget Cmte.; Comm. Dir., Sen. Mel Martinez; Dir., State Office of Sen. George Lemieux; Chief of Staff, Sen. George Lemieux
MICHAEL WERNER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.